Juvenile Dermatomyositis (JDM) (DBCOND0060450)

Identifiers

Synonyms
Dermatomyositis, Juvenile / Juvenile Dermatomyositis / Childhood type dermatomyositis (disorder) / Dermatomyositis, Childhood Type / Childhood dermatomyositis / Dermatopolymyositis, unspecified, organ involvement unspecified / Dermatopolymyositis, unspecified / Dermatomyositis / Dermatomyositis (disorder) / Dermatopolymyositis

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseasesprevention4recruiting
NCT01724580
Compassionate Use Protocol for the Treatment of Autoinflammatory SyndromesNot AvailableNot Availableno_longer_available
NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Respondersprevention2completed
NCT00059748
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05524311
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)treatment2recruiting
NCT00106184
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)treatment2completed
NCT03430388
Yellow Fever Vaccine in Patients With Rheumatic DiseasespreventionNot Availablecompleted
NCT01276470
Environmental Risk Factors for the Anti-synthetase SyndromeNo drug interventionsNot AvailableNot Availablerecruiting
NCT05545839
Transition to Adulthood Through Coaching and Empowerment in RheumatologyNo drug interventionssupportive_careNot Availablerecruiting
NCT00815282
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune DiseaseNo drug interventionsdiagnostic4completed
NCT00323960
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositistreatment3completed
NCT06556992
Fitness Integrative Training for Pediatric Rheumatology DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT06569472
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile DermatomyositisNo drug interventionstreatment1recruiting
NCT01697254
The CARRA RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT02267005
The Effect of Creatine Supplementation on Muscle Function in Childhood MyositisNo drug interventionssupportive_careNot Availablecompleted
NCT02245841
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositistreatment4completed
NCT01217320
Creatine Supplementation in Pediatric RheumatologyNo drug interventionstreatmentNot Availableunknown_status
NCT05509140
Clinical Analysis of Juvenile Dermatomyositis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03432455
Incidence and Prevalence of Juvenile DermatomyositisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03433638
Juvenile DermatomyositisNo drug interventionsNot AvailableNot Availableunknown_status